Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells. (Q38787063)
Jump to navigation
Jump to search
scientific article published on 08 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells. |
scientific article published on 08 March 2016 |
Statements
Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells (English)
Andy Göbel
Stefanie Thiele
Andrew J Browne
Martina Rauner
Valentina M Zinna
Tilman D Rachner